Author:
Eitzman Daniel T.,Ginsburg David
Reference42 articles.
1. . Francis CW, Marder VJ: Physiologic regulation and pathologic disorders of fibrinolysis, in Colman RW, Hirsh J, Marder VJ, Salzman EW (eds): Hemostasis and Thrombosis. Basic Principles and Clinical Practice, Philadelphia, J. B. Lippincott Company, 1987, p 358
2. . Loskutoff DJ, Sawdey M, Mimuro J: Type 1 plasminogen activator inhibitor. Prog Hemost Thromb 9: 87, 1989
3. . Lawrence D, Strandberg L, Grundström T, Ny T: Purification of active human plasminogen activator inhibitor I from Escherichia coli. Comparison with natural and recombinant forms purified from eucaryotic cells. Eur J Biochem 186: 523, 1989
4. . Declerck PJ, De Mol M, Alessi MC, Baudner S, Pâques E-P, Preissner KT, Müller-Berghaus G, Collen D: Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein. J Biol Chem 263: 15454, 1988
5. . Kruithof EKO, Baker MS, Bunn CL: Biological and clinical aspects of plasminogen activator inhibitor type 2 (PAI-2). Blood 86: 4007, 1995
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献